Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions

被引:64
作者
Pediconi, Federica
Catalano, Carlo
Roselli, Antonella
Padula, Simona
Altomari, Fiorella
Moriconi, Enrica
Pronio, Anna Maria
Kirchin, Miles A.
Passariello, Roberto
机构
[1] Univ Roma La Sapienza, Dept Radiol Sci, I-00161 Rome, Italy
[2] Univ Roma La Sapienza, Dept Surg, I-00161 Rome, Italy
[3] Bracco Imaging, Dept Worldwide Med Affairs, Milan, Italy
关键词
D O I
10.1148/radiol.2433060838
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To prospectively evaluate accuracy of gadobenate dimeglumine-enhanced magnetic resonance ( MR) mammography for depiction of synchronous contralateral breast cancer in patients with newly diagnosed unilateral breast cancer or high-risk lesions, with histologic analysis or follow-up as reference. Materials and Methods: The study had ethics committee approval; all patients provided written informed consent. One hundred eighteen consecutive women ( mean age, 52 years) with unilateral breast cancer or high-risk lesions and negative findings in the contralateral breast at physical examination, ultrasonography, and conventional mammography underwent gadobenate dimeglumine-enhanced 1.5-T MR mammography. Transverse three-dimensional T1-weighted gradient-echo images were acquired before and at 0, 2, 4, 6, and 8 minutes after gadobenate dimeglumine administration ( 0.1 mmol per kilogram body weight). Breast Imaging Reporting and Data System ( BI-RADS) was used to categorize breast density and the level of suspicion for malignant contralateral breast lesions. Results were compared with histologic findings. Sensitivity, specificity, accuracy, and positive and negative predictive values for contrast-enhanced MR mammography were evaluated. Results: Contrast-enhanced MR mammography revealed contralateral lesions in 28 ( 24%) of 118 patients. Twenty-four lesions were detected in patients with dense breasts ( BI-RADS breast density category III or IV). Lesions in eight ( 29%) of 28 patients were BI-RADS category 4; patients underwent biopsy. Lesions in 20 ( 71%) patients were BI-RADS category 5; patients underwent surgery. At histologic analysis, 22 lesions were confirmed as malignant; six lesions were fibroadenomas. No false-negative lesions were detected; none of the fibroadenomas were BI-RADS category 5. The sensitivity, specificity, accuracy, and positive and negative predictive values of contrast-enhanced MR mammography for depiction of malignant or high-risk contralateral lesions were 100%, 94%, 95%, 79%, and 100%, respectively. Follow-up findings ( 12-24 months) confirmed absence of contralateral lesions in 90 of 118 patients with negative contrast-enhanced MR mammographic findings in the contralateral breast. Conclusion: Contrast-enhanced MR mammography is accurate for detection of synchronous contralateral cancer or high-risk lesions in patients with newly diagnosed breast cancer or high-risk lesions. (c) RSNA, 2007.
引用
收藏
页码:670 / 680
页数:11
相关论文
共 53 条
  • [1] [Anonymous], 2003, BREAST IM REP DAT SY
  • [2] BREAST-TUMORS - COMPARATIVE ACCURACY OF MR-IMAGING RELATIVE TO MAMMOGRAPHY AND US FOR DEMONSTRATING EXTENT
    BOETES, C
    MUS, RDM
    HOLLAND, R
    BARENTSZ, JO
    STRIJK, SP
    WOBBES, T
    HENDRIKS, JHCL
    RUYS, SHJ
    [J]. RADIOLOGY, 1995, 197 (03) : 743 - 747
  • [3] Boetes C, 2005, Cancer Imaging, V5 Spec No A, pS10, DOI 10.1102/1470-7330.2005.0040
  • [4] Gadolinium chelates with weak binding to serum proteins - A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging
    Cavagna, FM
    Maggioni, F
    Castelli, PM
    Dapra, M
    Imperatori, LG
    Lorusso, V
    Jenkins, BG
    [J]. INVESTIGATIVE RADIOLOGY, 1997, 32 (12) : 780 - 796
  • [5] The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy
    Cecil, KM
    Schnall, MD
    Siegelman, ES
    Lenkinski, RE
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 68 (01) : 45 - 54
  • [6] Chen Y, 1999, CANCER EPIDEM BIOMAR, V8, P855
  • [7] Macromolecular contrast agents for MR mammography: current status
    Daldrup-Link, HE
    Brasch, RC
    [J]. EUROPEAN RADIOLOGY, 2003, 13 (02) : 354 - 365
  • [8] MR imaging features of breast lymphoma
    Demirkazik, FB
    [J]. EUROPEAN JOURNAL OF RADIOLOGY, 2002, 42 (01) : 62 - 64
  • [9] Overall breast density in MR mammography -: Diagnostic and therapeutic implications in breast cancer
    Echevarria, JJ
    Martín, M
    Saiz, A
    Imaz, I
    Férnandez-Ruanova, B
    Martín, D
    López-Ruiz, JA
    [J]. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2006, 30 (01) : 140 - 147
  • [10] Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: Is excisional biopsy necessary?
    Foster, MC
    Helvie, MA
    Gregory, NE
    Rebner, M
    Nees, AV
    Paramagul, C
    [J]. RADIOLOGY, 2004, 231 (03) : 813 - 819